AMG 510 Expanded access ex EU (w/LTFU)
Research payments
$362,537
Through program year 2023, $362,537 in research payments was reported against AMG 510 Expanded access ex EU (w/LTFU), across 102 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $1,488 | 10 |
| 2022 | Research | $9,133 | 17 |
| 2021 | Research | $349,631 | 73 |
| 2020 | Research | $2,285 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mary Huerter Iowa City, IA Named on 4 payments
- Sujith Kalmadi Chandler, AZ Named on 4 payments
- Raymond Osarogiagbon Memphis, TN Named on 3 payments
- Mark Awad Boston, MA Named on 3 payments
- Neil Morganstein Summit, NJ Named on 3 payments
- Yelena Patsiornik Mesa, AZ Named on 3 payments
- Janakiraman Subramanian Kansas City, MO Named on 3 payments
- Jorge Diaz Huntsville, AL Named on 2 payments
- Jessica Croley Lexington, KY Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.